Genetic variability at the amyloid-β precursor protein locus may contribute to the risk of late-onset Alzheimer's disease
Section snippets
Acknowledgements
This work was supported by the Medical Research Council (UK), the Mayo Foundation, the National Institute of Health, the Alzheimer's Disease Association and the Nettie and Rebecca Brown Foundation. The samples were collected as part of the NIMH Alzheimer's genetic initiative (Ref. [2]).
References (28)
- et al.
APP gene promoter constructs are preferentially expressed in the CNS and testis of transgenic mice
Biochem. Biophys. Res. Commun.
(1997) An upstream region of the gene promoter for the beta-amyloid precursor protein interacts with proteins from nuclear extracts of the human brain and PC12 cells
Mol. Brain Res.
(1998)- et al.
The promoter activity of the gene encoding Alzheimer beta-amyloid precursor protein (APP) is regulated by two blocks of upstream sequences
Mol. Brain Res.
(1991) - et al.
The amyloid beta-protein precursor promoter. A region essential for transcriptional activity contains a nuclear factor binding domain
J. Biol. Chem.
(1992) - et al.
Molecular cloning of the gene encoding the Rbesus monkey β-amyloid precursor protein: structural characterization of the promoter and comparative study with other species
Gene
(1998) - et al.
Functional identification of the promoter of the gene encoding the Rhesus monkey β-amyloid precursor protein
Gene
(1998) - et al.
The zinc finger protein CTCF binds to the APB beta domain of the amyloid beta-protein precursor promoter. Evidence for a role in transcriptional activation
J. Biol. Chem.
(1997) - et al.
Alzheimer's Disease Collaborative Group. Genetic association between intronic polymorphism in presenilin-1gene and late-onset Alzheimer's disease
Lancet
(1996) - et al.
Nucleolin and heterogeneous nuclear ribonucleoprotein C proteins specifically interact with the 5′-untranslated region of amyloid protein precursor mRNA
J. Biol. Chem.
(1995) - et al.
Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition
Nat Genet.
(1997)
ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative
Neurology
Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region
Hum. Mol. Genet.
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
Science
Deficiency of presenilin-l inhibits the normal cleavage of amyloid precursor protein
Nature
Cited by (41)
Proteomic and metabolomic biomarkers of Alzheimer’s disease: Opportunities to advance precision medicine and clinical trials
2021, The Neurobiology of Aging and Alzheimer Disease in Down SyndromeMarkers of neural degeneration and regeneration in Down syndrome patients
2013, Egyptian Journal of Medical Human GeneticsCitation Excerpt :The significant increase in Aβ42 in DS compared to controls in the present study is due to the APP gene, located on the long arm of extra expressed chromosome 21 [5,7,24]. Aß42 progressively accumulates in the brain as neuritic plaques contributing to the association of dementia in DS and AD [25,26] and age-dependent cognitive sequelae [27,28]. The significant increase of Aβ42 among adolescent DS compared to young DS gives an indication that Aβ42 increases by aging in DS patients.
Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease
2006, American Journal of Human GeneticsChromosome 21 BACE2 haplotype associates with Alzheimer's disease: A two-stage study
2005, Journal of the Neurological SciencesCausative and susceptibility genes for Alzheimer's disease: A review
2003, Brain Research Bulletin